Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from transplantation and future perspectives

S A Birkeland

    Transplant International : Official Journal of the European Society for Organ Transplantation
    |December 31, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

    Transplantation·2003
    Same author

    Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.

    Transplantation·2003
    Same author

    [The history of transplantation].

    Dansk medicinhistorisk arbog·2001
    Same author

    Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.

    Transplantation·2001
    Same author

    Cancer risk in patients on dialysis and after renal transplantation.

    Lancet (London, England)·2000
    Same author

    Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.

    Transplantation·1999
    Same journal

    Cold ischemia time exceeding 12 hours is a risk factor for delayed graft function and increased mortality in kidney transplant recipients within the eurotransplant senior program.

    Transplant international : official journal of the European Society for Organ Transplantation·2026
    Same journal

    Impact of pre-transplantation exposure to immunosuppressive agents on lung transplant outcomes in interstitial lung disease.

    Transplant international : official journal of the European Society for Organ Transplantation·2026
    Same journal

    Delayed graft function and long-term outcomes after deceased donor kidney transplantation: insights from mate-kidney analysis.

    Transplant international : official journal of the European Society for Organ Transplantation·2026
    Same journal

    Regulatory approach to manipulated organs in Europe: preserving human organs as non-commercial goods.

    Transplant international : official journal of the European Society for Organ Transplantation·2026
    Same journal

    Can european law keep pace with biomedical innovation? The reinvention of transplantation regulation.

    Transplant international : official journal of the European Society for Organ Transplantation·2026
    Same journal

    Sex-related differences in survival based on [<sup>18</sup>F]FDG PET/CT metabolic tumor volume after liver transplantation for colorectal liver metastases.

    Transplant international : official journal of the European Society for Organ Transplantation·2026
    See all related articles

    Organ transplantation offers life extension for chronic diseases. Temporary organ replacement allows recovery, potentially through common mechanisms like apoptosis, opening new therapeutic avenues.

    Area of Science:

    • Medicine
    • Transplantation Biology
    • Cellular Biology

    Background:

    • Organ transplantation is a standard treatment for end-stage organ failure in kidney, heart, lung, and liver diseases.
    • Significant advancements have been made in understanding disease progression and organ replacement therapies.
    • The study reflects on cross-disciplinary lessons learned from organ transplantation and related treatments.

    Discussion:

    • Explores temporary organ replacement as a strategy for organ recovery during critical illness.
    • Investigates the potential for a common underlying mechanism, such as apoptosis, across diverse diseases.
    • Highlights the development of pharmacological interventions targeting apoptosis to enhance organ recovery.

    Key Insights:

    • Temporary organ replacement facilitates organ quiescence and functional recovery.

    Related Experiment Videos

  • Apoptosis may represent a unifying mechanism in various organ-specific diseases.
  • Targeting apoptosis holds promise for reducing organ recovery times.

    • Outlook:

    • Further research is needed to fully explore the potential of temporary organ replacement.
    • Investigating common disease mechanisms like apoptosis could lead to novel therapeutic strategies.
    • Continued exploration of cross-disciplinary lessons can advance overall medical practice.